This bill requires federal health agencies to develop two new strategies within the National Health Security Strategy. First, a "biological attribution strategy" to clarify which agencies handle identifying the source of biological threats (like disease outbreaks) and how they coordinate, including using new technologies for detection. Second, an "early warning strategy" focused on rapidly spotting emerging health threats (biological, chemical, or radiological) through tools like wastewater testing and airport screenings, while avoiding duplicated efforts. It mandates coordination with state health departments, private labs, and intelligence agencies to streamline response capabilities. The bill directly affects federal agencies (like CDC and National Intelligence) and their coordination with state/local partners, without creating new funding or altering existing laws.
HR 2767, the BRAIN Act, aims to advance brain tumor research and improve patient care by requiring the NIH to create a public database of tumor samples collected with federal funding. It authorizes $50 million annually for a Glioblastoma Therapeutics Network to accelerate treatment development and $10 million for cellular immunotherapy research (including CAR-T therapies) targeting brain tumors. The bill also mandates a national awareness campaign to increase understanding of cancer clinical trials and biomarker testing, plus $5 million yearly for pilot programs studying survivor care coordination and follow-up services. Additionally, it directs the FDA to issue guidance ensuring brain tumor patients can access clinical trials. These provisions directly affect patients, researchers, and healthcare providers focused on brain tumors and rare cancers.
The Transportation Freedom Act would create a 200% tax deduction for wages paid to U.S. automobile manufacturing workers who meet specific requirements, including health care coverage and pension benefits. It repeals current emissions standards for light-duty, medium-duty, and heavy-duty vehicles, as well as Corporate Average Fuel Economy (CAFE) standards. The bill establishes new standards for greenhouse gas emissions and fuel economy that must be "technologically feasible and economically practicable," requiring consultation with manufacturers and other stakeholders. It also eliminates existing emissions waivers and creates a process for adjusting standards based on market conditions.
HR 996 extends and enhances a tax credit for employers that provide paid family and medical leave to employees. The bill gives eligible employers two options for claiming the credit: either a percentage of wages paid to employees on leave or a percentage of premiums paid for an insurance policy covering such leave (calculated as if leave were always available). It clarifies that state or local government-paid leave counts toward an employer’s leave provision but not toward the credit amount, and prevents double benefits by disallowing deductions for expenses used to claim the credit. The Small Business Administration and Internal Revenue Service must conduct outreach to help employers understand and access this credit.
The Keep Kids Covered Act extends continuous health coverage under Medicaid and CHIP for children. It requires states to maintain coverage for children under age 6 for six years (previously one year) and for children under age 19 for two years (previously one year), without requiring reapplication. Former foster youth will now remain covered until age 26. States must also annually update contact information for enrolled children and inform them about their coverage status and remaining eligibility period.
HR 4516, the Saving Lives and Taxpayer Dollars Act, prohibits the U.S. government or its aid partners from destroying food, medicine, vaccines, or other foreign assistance commodities before they expire, requiring these items to be redirected to intended beneficiaries instead. The bill mandates that agencies like USAID, State, and Agriculture must make every effort to donate or sell expired aid items to those in need before disposal. It also requires annual reports to Congress detailing any expired, spoiled, or destroyed aid items, including reasons for not redirecting them and associated costs. This directly affects U.S. foreign aid agencies and their global partners, ensuring aid reaches people facing hunger, disease, or health crises rather than being wasted.
This bill modifies tax rules for health savings accounts (HSAs) to help employees transition from health flexible spending accounts (FSAs) or health reimbursement arrangements (HRAs) to HSAs when switching to a high-deductible health plan. It allows employees to transfer unused FSA/HRA funds directly to an HSA during the plan year, with limits based on existing HSA contribution rules. Employers must report these transfers on employees' W-2 forms as taxable compensation. The changes apply to transfers made after December 2025 and primarily affect workers using employer-sponsored health benefits who switch coverage types.
This bill prohibits state officials from blocking abortion access for patients traveling from other states, including restricting providers who offer legal abortions in their state to out-of-state patients. It protects people traveling across state lines for legal abortions, those assisting such travel, and the interstate transport of FDA-approved abortion medication. Violations can be challenged by the Justice Department or affected individuals through civil lawsuits seeking injunctions and damages. The law applies broadly across all states, territories, and tribal nations, defining "abortion service" to include both medical procedures and related care.
This bill authorizes the U.S. Department of Health and Human Services to collect registration fees from Organ Procurement and Transplantation Network (OPTN) members (including hospitals and transplant centers) for each transplant candidate listed on the OPTN registry. The fees, collected per candidate, must be used solely to support OPTN operations and cannot be used for other purposes. The bill requires quarterly transparency updates on the OPTN website showing fee amounts collected and how they are spent, and mandates a government review within two years. The fee collection authority expires after three years from the bill’s enactment.
This bill ensures Medicare covers and pays for skin substitute products (used in wound care) by creating a new payment system starting in 2026. It establishes a payment rate based on a volume-weighted average of past payment data, adjusted annually for inflation, and requires a new billing code for these products by January 2026. The bill also adds program integrity measures: identifying the top 3% of providers by payment volume (outliers) for extra review, and requiring prior authorization for their claims starting in 2027. Additionally, it mandates coverage for these products in 2026 unless unsafe, and prohibits denying coverage solely based on clinical evidence analysis.
